269 related articles for article (PubMed ID: 14966573)
1. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.
Preitner F; Ibberson M; Franklin I; Binnert C; Pende M; Gjinovci A; Hansotia T; Drucker DJ; Wollheim C; Burcelin R; Thorens B
J Clin Invest; 2004 Feb; 113(4):635-45. PubMed ID: 14966573
[TBL] [Abstract][Full Text] [Related]
2. Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice.
Tura A; Pacini G; Yamada Y; Seino Y; Ahrén B
Am J Physiol Regul Integr Comp Physiol; 2019 Jan; 316(1):R27-R37. PubMed ID: 30462524
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of circulating GIP and GLP-1 concentrations.
Almgren P; Lindqvist A; Krus U; Hakaste L; Ottosson-Laakso E; Asplund O; Sonestedt E; Prasad RB; Laurila E; Orho-Melander M; Melander O; Tuomi T; Holst JJ; Nilsson PM; Wierup N; Groop L; Ahlqvist E
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093273
[TBL] [Abstract][Full Text] [Related]
4. The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice.
Ahrén B; Yamada Y; Seino Y
Front Endocrinol (Lausanne); 2021; 12():665537. PubMed ID: 34122340
[TBL] [Abstract][Full Text] [Related]
5. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor.
Graham GV; Conlon JM; Abdel-Wahab YH; Gault VA; Flatt PR
Peptides; 2018 Feb; 100():182-189. PubMed ID: 29157578
[TBL] [Abstract][Full Text] [Related]
7. The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db/db mice.
Meng Q; Chepurny OG; Leech CA; Pruekprasert N; Molnar ME; Collier JJ; Cooney RN; Holz GG
Diabetes Obes Metab; 2022 Jul; 24(7):1255-1266. PubMed ID: 35293666
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion.
Yan S; Conley JM; Reilly AM; Stull ND; Abhyankar SD; Ericsson AC; Kono T; Molosh AI; Kubal CA; Evans-Molina C; Ren H
Cell Rep; 2022 Jan; 38(1):110179. PubMed ID: 34986353
[TBL] [Abstract][Full Text] [Related]
9. Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.
Mezza T; Moffa S; Ferraro PM; Quero G; Capece U; Carfì A; Cefalo CMA; Cinti F; Sorice GP; Impronta F; Mari A; Pontecorvi A; Alfieri S; Holst JJ; Giaccari A
J Clin Endocrinol Metab; 2019 Jul; 104(7):2685-2694. PubMed ID: 30874733
[TBL] [Abstract][Full Text] [Related]
10. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 and glucose-dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice.
Pacini G; Ahrén B
Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28611149
[TBL] [Abstract][Full Text] [Related]
12. GIP(3-30)NH
Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
[TBL] [Abstract][Full Text] [Related]
13. An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice.
Ma T; Lu W; Wang Y; Qian P; Tian H; Gao X; Yao W
Eur J Pharmacol; 2022 Jan; 914():174635. PubMed ID: 34800466
[TBL] [Abstract][Full Text] [Related]
14. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
Akindehin S; Liskiewicz A; Liskiewicz D; Bernecker M; Garcia-Caceres C; Drucker DJ; Finan B; Grandl G; Gutgesell R; Hofmann SM; Khalil A; Liu X; Cota P; Bakhti M; Czarnecki O; Bastidas-Ponce A; Lickert H; Kang L; Maity G; Novikoff A; Parlee S; Pathak E; Schriever SC; Sterr M; Ussar S; Zhang Q; DiMarchi R; Tschöp MH; Pfluger PT; Douros JD; Müller TD
Mol Metab; 2024 May; 83():101915. PubMed ID: 38492844
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
Yuliantie E; Darbalaei S; Dai A; Zhao P; Yang D; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2020 Jul; 177():114001. PubMed ID: 32360365
[TBL] [Abstract][Full Text] [Related]
16. Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?
Yabe D; Seino Y; Seino Y
J Diabetes Investig; 2018 Jan; 9(1):21-24. PubMed ID: 28746743
[TBL] [Abstract][Full Text] [Related]
17. The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones.
Rudenko O; Shang J; Munk A; Ekberg JP; Petersen N; Engelstoft MS; Egerod KL; Hjorth SA; Wu M; Feng Y; Zhou YP; Mokrosinski J; Thams P; Reimann F; Gribble F; Rehfeld JF; Holst JJ; Treebak JT; Howard AD; Schwartz TW
Mol Metab; 2019 Jan; 19():49-64. PubMed ID: 30472415
[TBL] [Abstract][Full Text] [Related]
18. Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.
Wice BM; Wang S; Crimmins DL; Diggs-Andrews KA; Althage MC; Ford EL; Tran H; Ohlendorf M; Griest TA; Wang Q; Fisher SJ; Ladenson JH; Polonsky KS
J Biol Chem; 2010 Jun; 285(26):19842-53. PubMed ID: 20421298
[TBL] [Abstract][Full Text] [Related]
19. The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets.
El K; Douros JD; Willard FS; Novikoff A; Sargsyan A; Perez-Tilve D; Wainscott DB; Yang B; Chen A; Wothe D; Coupland C; Tschöp MH; Finan B; D'Alessio DA; Sloop KW; Müller TD; Campbell JE
Nat Metab; 2023 Jun; 5(6):945-954. PubMed ID: 37277609
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Melatonin on Incretin Hormones: Results From Experimental and Randomized Clinical Studies.
Lauritzen ES; Støy J; Bæch-Laursen C; Grarup N; Jessen N; Hansen T; Møller N; Hartmann B; Holst JJ; Kampmann U
J Clin Endocrinol Metab; 2021 Nov; 106(12):e5109-e5123. PubMed ID: 34265066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
